CFMTI

CAS No. 864864-17-5

CFMTI( CFMTI )

Catalog No. M17627 CAS No. 864864-17-5

CFMTI is a potent and selective metabotropic glutamate receptor (mGluR) 1 allosteric antagonist (IC50: 2.6 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 136 In Stock
2MG 75 In Stock
5MG 123 In Stock
10MG 180 In Stock
25MG 321 In Stock
50MG 445 In Stock
100MG 621 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CFMTI
  • Note
    Research use only, not for human use.
  • Brief Description
    CFMTI is a potent and selective metabotropic glutamate receptor (mGluR) 1 allosteric antagonist (IC50: 2.6 nM).
  • Description
    CFMTI is a potent and selective metabotropic glutamate receptor (mGluR) 1 allosteric antagonist (IC50: 2.6 nM). The selectivity of CFMTI to mGluR1 is higher 2000-fold than mGluR5.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CFMTI
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    mGluR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    864864-17-5
  • Formula Weight
    349.37
  • Molecular Formula
    C19H16FN5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 6.2 mg/mL. 17.75 mM;
  • SMILES
    c1(c(nccc1)F)n1nnc(c1C)c1ccc2c(c1)CN(C2=O)C1CC1
  • Chemical Name
    2-Cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Satow A et al. 2009 Jul;330(1):179-90.
molnova catalog
related products
  • β-Amyloid 33-40

    β-Amyloid (33-40) is a peptide consisting of amino acid of 33 to 40 of beta amyloid protein.

  • MK-3328

    MK-3328 has a high affinity for β-Amyloid (IC50:10.5 nM), and can be used as a candidate PET ligand for clinical assessment of β-amyloid plaque load. MK-3328 is a potential treatment for Alzheimer's disease.

  • β-Amyloid (10-35), a...

    β-Amyloid (10-35), amide is composed of 26 aa (10-35 residues of the Aβ peptide) and is the primary component of the amyloid plaques of Alzheimer’s disease.